Department of Neurobiology and Behavior, University of California Irvine, Irvine, California.
Sue and Bill Gross Stem Cell Research Center, University of California Irvine, Irvine, California.
Glia. 2020 Apr;68(4):721-739. doi: 10.1002/glia.23781. Epub 2020 Jan 11.
Recent advances in the generation of microglia from human induced pluripotent stem cells (iPSCs) have provided exciting new approaches to examine and decipher the biology of microglia. As these techniques continue to evolve to encompass more complex in situ and in vivo paradigms, so too have they begun to yield novel scientific insight into the genetics and function of human microglia. As such, researchers now have access to a toolset comprised of three unique "flavors" of iPSC-derived microglia: in vitro microglia (iMGs), organoid microglia (oMGs), and xenotransplanted microglia (xMGs). The goal of this review is to discuss the variety of research applications that each of these techniques enables and to highlight recent discoveries that these methods have begun to uncover. By presenting the research paradigms in which each model has been successful, as well as the key benefits and limitations of each approach, it is our hope that this review will help interested researchers to incorporate these techniques into their studies, collectively advancing our understanding of human microglia biology.
最近在利用人诱导多能干细胞(iPSC)生成小胶质细胞方面的进展为研究和解析小胶质细胞的生物学特性提供了令人兴奋的新方法。随着这些技术不断发展,涵盖更复杂的原位和体内范例,它们也开始为人类小胶质细胞的遗传学和功能提供新的科学见解。因此,研究人员现在可以使用三种独特的 iPSC 衍生小胶质细胞工具包:体外小胶质细胞(iMGs)、类器官小胶质细胞(oMGs)和异种移植小胶质细胞(xMGs)。本综述的目的是讨论每种技术可实现的各种研究应用,并强调这些方法开始揭示的最新发现。通过介绍每种模型成功的研究范例,以及每种方法的关键优势和局限性,我们希望本综述将帮助有兴趣的研究人员将这些技术纳入他们的研究中,共同推进我们对人类小胶质细胞生物学的理解。